PredicTx Health

Startup

PredicTx Health is building a clinical decision support platform that personalises chemotherapy treatment using routine imaging and patient data.

Today, chemotherapy dosing is still based on body surface area, a 50-year-old method that does not account for individual patient differences. This leads to high rates of toxicity, treatment delays, and suboptimal outcomes.

Our platform, OncoTx, uses body composition analysis from standard CT scans combined with clinical data to provide patient-specific insights that support more precise treatment decisions.

We work directly within existing hospital workflows, integrating with oncology systems to deliver insights at the point of care without disrupting clinicians.

PredicTx is a University of Melbourne spin-out, backed by over 7 years of clinical research and collaborating with leading hospital networks across Australia.

website